PLK1 and neoplasm: Liposomal mediated delivery of PLK1-siRNA and KSP-siRNA significantly inhibited the PLK1-mRNA and KSP-mRNA expression levels in hepatic cancer cell model and thus enhanced the survival rate of tumor bearing mice.